The CONFORMAL Early Feasibility Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 22, 2019

Primary Completion Date

May 27, 2022

Study Completion Date

June 30, 2025

Conditions
Non-valvular Atrial Fibrillation
Interventions
DEVICE

left atrial appendage closure

Closure of the left atrial appendage (LAAC) is performed percutaneously. Implantation of the CLAAS device will be performed according to device specific instructions for use based on both TEE guidance, ICE and angiography, femoral access and inter-atrial septum crossing

Trial Locations (11)

10029

Mount Sinai, New York

10032

Columbia University Medical Center/NYPH, New York

19096

Lankenau Heart Institute, Wynnewood

37232

Vanderbilt University Medical Center, Nashville

37403

Erlanger Health System, Chattanooga

45219

The Christ Hospital, Cincinnati

72401

St. Bernards Medical Center, Jonesboro

75093

Baylor Scott & white Research Institute, Plano

78705

Texas Cardiac Arrhythmia Institute, Austin

90404

Pacific Heart Institute, Santa Monica

03102

Catholic Medical Center, Manchester

Sponsors
All Listed Sponsors
collaborator

Yale Cardiovascular Research Group

OTHER

lead

Conformal Medical, Inc

INDUSTRY